Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application
Novo Integrated Sciences Effects Reverse Stock Split in Connection with Nasdaq Capital Market Listing Application Novo Integrated Sciences, Inc. (OTCQB:NVOS) (OTCQB:NVOSD), a provider of multi-dimensional primary healthcare services and products in Canada and the U.S. (the Company”), announced today it has effected a 1-for-10 reverse split of its common stock effective prior to the opening of the market today, Monday, February 1, 2021. Beginning today, the Companys common stock will trade on a post-split basis under the symbol NVOSD. After 20 business days, the common stock will return to trading under the symbol NVOS. As a result of the reverse stock split, the CUSIP number for the Companys common stock has changed. The new CUSIP number for the Companys common stock is 67011T 201.
Aramark Nominates Bridgette Heller to Board of Directors
Aramark Nominates Bridgette Heller to Board of Directors Aramark (NYSE:ARMK), a global leader in food, facilities management and uniforms, announced today that Bridgette Heller has been nominated for election to the Companys Board of Directors at its annual meeting of shareholders to be held on February 2, 2021. A highly respected global business leader with 35 years of experience in food, health & wellness and consumer care, Heller most recently served as the President of Nutricia, the Specialized Nutrition Division of Danone. During her tenure, Hellers organization achieved industry-leading growth and profitability, while simultaneously championing diversity and inclusion. From 2010-2015, Heller served as Executive Vice President of Merck & Co. and President of Merck Consumer Care. Prior to joining Merck, she was President of Johnson & Johnsons Global Baby Business Unit. Heller began her career at Kraft Foods, where